STING Pathway:

Using a Tumor’s Composition to Activate an Immune Response

Learn More

B-select Antibodies:

Modulating Cancer Immunity 

Learn More

LADD®:

Harnessing the Power of Bacteria to Direct the Immune Response Against Cancer

Learn More

Immunotherapy

Learn how immunotherapies harness a person’s immune system to fight cancer

Learn More

Clinical Trials

Learn more about Aduro’s clinical programs

Learn More

Investors

Download the 2017 Annual Report

Download PDF

Recent News

September 19, 2018 Aduro Biotech Announces the Departure of Natalie R. Sacks, M.D.

September 04, 2018 Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia

September 04, 2018 Aduro Biotech Presents Preclinical Data for BION-1301, a First-in-Class Antibody Targeting Human APRIL, at the 2018 European Congress of Immunology

Read More

Careers

Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?

Learn More

Media

Learn how Aduro is developing revolutionary new therapies to treat cancers

Learn More